Impact of Music Therapy on Pain in Patients Treated for Advanced Cancer (MSPD)

February 11, 2025 updated by: Institut du Cancer de Montpellier - Val d'Aurelle
The aim of this study is to assess the impact of music therapy on the pain of patients cared at the Montpellier Cancer Institute (ICM) for advanced cancer in a palliative situation and requiring full hospitalization or on an outpatient basis.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Music therapy is a care practice that falls within the field of support, help and accompaniment therapies. Sound, musical and music are the means used to support, maintain or improve a person's physical and mental health.

The patients involved in the study are patients cared at the ICM for advanced cancer in a palliative situation and requiring full hospitalization or on an outpatient basis.

The aim is to assess the impact of music therapy on the pain of these patients. The patient is proposed to participate in a music therapy session. Before this session, the music therapist will assess the pain and the presence of symptoms with the patient.

Following this exchange, she will define the device best suited to his expectations and his needs and will propose his a relaxation session induced by music.

After the session the music therapist will assess with the patient the pain and the presence of symptoms.

The patient's feelings and satisfaction about this music therapy session as well as his possible wish to participate in another session will also be evaluated.

Study Type

Interventional

Enrollment (Actual)

41

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Montpellier, France, 34298
        • Institut du Cancer de Montpellier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Study Population

The 40 patients will be included among the patients cared at the ICM for advanced cancer in a palliative situation and requiring full hospitalization or on an outpatient basis.

Description

Inclusion Criteria:

  • Male/female over 18 years old
  • Patient cared for at the ICM for advanced cancer followed by the Mobile Palliative and/or Pain Care Team
  • Patient with pain score >= 3 (cancer related)
  • Patient who accepts a music therapy session
  • Patient having expressed his oral non-opposition
  • Patient able to communicate
  • Patient affiliated to the French Social Security System.

Exclusion Criteria:

  • Patient with uncorrected hearing loss to normal
  • Patient under guardianship, curatorship or safeguard of justice

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Evaluation of the impact of music therapy on the pain of patients
One music therapy session
Other: one music therapy session
Edmonton Symptom Assessment System (ESAS) scale (before and after music therapy session), Numerical pain scale (before and after music therapy session)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change between before and after music therapy session on patients pain
Time Frame: at day 1 (before and after the music therapy session)
Evolution of pain assessed by a numerical pain scale ranging from 0 to 10 (10 indicating the highest degree of pain)
at day 1 (before and after the music therapy session)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Description of symptom management
Time Frame: at day 1 (before and after the music therapy session)

By the Edmonton Symptom Assessment System scale symptom score. This is a self-assessment scale of the most common symptoms in palliative care:pain, dyspnoea, fatigue, drowsiness, appetite, anxiety, depression, well-being and other possible symptoms. It's a numerical scale ranging from 0 to 10 (with higher scores indicating more severe symptoms).

The Edmonton Symptom Assessment System scale allows to:

  • Detect the symptoms present, quantify them and follow their evolution
  • Validate with the patient the symptoms that bother him and that he wishes to be treated as a priority
  • Communicate quickly between the different professionals involved in the treatment.
at day 1 (before and after the music therapy session)
Patient wishing a second session of music therapy
Time Frame: at day 1 (after the music therapy session)
Proportion of Patient wishing a second session of music therapy
at day 1 (after the music therapy session)
Patient satisfaction of the music therapy session
Time Frame: at day 1 (after the music therapy session)
Assessment of the satisfaction of the music therapy session. Assessment made by a numerical scale ranging from 0 to 10 (10 indicating high satisfaction)
at day 1 (after the music therapy session)
Agreement to participate in the study
Time Frame: at inclusion
Proportion of patients agreeing to participate among the eligible patients to whom the study was proposed
at inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle

Investigators

  • Study Chair: Caroline GALLAY, Institut du Cancer de Montpellier - Val d'aurelle

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 2, 2022

Primary Completion (Actual)

January 5, 2023

Study Completion (Actual)

January 5, 2023

Study Registration Dates

First Submitted

March 17, 2022

First Submitted That Met QC Criteria

March 29, 2022

First Posted (Actual)

April 7, 2022

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 11, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PROICM 2021-10 OMS
  • 2021-A02020-41 (Other Identifier: ID RCB number of competent autority in France)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Advanced Cancer

Clinical Trials on one music therapy session

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe